• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

APOE4增加对淀粉样蛋白的易感性,加速情景记忆衰退。

APOE4 Increases Susceptibility to Amyloid, Accelerating Episodic Memory Decline.

作者信息

Vanderlip Casey R, Stark Craig E L

机构信息

Department of Neurobiology and Behavior, University of California Irvine.

出版信息

bioRxiv. 2024 Dec 24:2024.12.23.630203. doi: 10.1101/2024.12.23.630203.

DOI:10.1101/2024.12.23.630203
PMID:39763904
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11703168/
Abstract

Apolipoprotein E4 (APOE4) is the strongest genetic risk factor for sporadic Alzheimer's disease (AD). Individuals with one copy of APOE4 exhibit greater amyloid-beta (Aβ) deposition compared to noncarriers, an effect that is even more pronounced in APOE4 homozygotes. Interestingly, APOE4 carriers not only show more AD pathology but also experience more rapid cognitive decline, particularly in episodic memory. The underlying mechanisms driving this domain-specific vulnerability, however, remain unclear. In this study, we examined whether the accelerated decline in episodic memory among APOE4 carriers is due to increased Aβ deposition or heightened susceptibility to Aβ-related effects. Using data from the Alzheimer's Disease Research Initiative, we modeled amyloid duration, the estimated number of years an individual has been amyloid-positive, and its impact on cognitive trajectories. Our findings reveal that APOE4 is associated with more rapid episodic memory decline as a function of amyloid duration. This decline was dose-dependent, with APOE4 homozygotes declining more rapidly than heterozygotes, and it was consistently observed across multiple episodic memory tasks and measures. Importantly, this pattern was not observed in other cognitive domains, such as processing speed, executive function, visuospatial skills, language, or crystallized intelligence. These results suggest that cognitive trajectories in AD differ by APOE genotype, with APOE4 conferring increased vulnerability to hippocampal dysfunction early in the disease course. Future research should investigate whether these cognitive differences stem from distinct pathological cascades in APOE4 carriers.

摘要

载脂蛋白E4(APOE4)是散发性阿尔茨海默病(AD)最强的遗传风险因素。与非携带者相比,携带一份APOE4的个体表现出更多的β淀粉样蛋白(Aβ)沉积,这种效应在APOE4纯合子中更为明显。有趣的是,APOE4携带者不仅表现出更多的AD病理学特征,而且认知衰退更快,尤其是在情景记忆方面。然而,导致这种特定领域易损性的潜在机制仍不清楚。在本研究中,我们研究了APOE4携带者情景记忆加速衰退是由于Aβ沉积增加还是对Aβ相关效应的易感性增加。利用阿尔茨海默病研究倡议的数据,我们建立了淀粉样蛋白持续时间的模型,即个体淀粉样蛋白呈阳性的估计年数,及其对认知轨迹的影响。我们的研究结果表明,APOE4与情景记忆随淀粉样蛋白持续时间的更快衰退有关。这种衰退是剂量依赖性的,APOE4纯合子比杂合子衰退更快,并且在多个情景记忆任务和测量中一致观察到。重要的是,在其他认知领域,如处理速度、执行功能、视觉空间技能、语言或晶体智力中未观察到这种模式。这些结果表明,AD中的认知轨迹因APOE基因型而异,APOE4在疾病早期使海马功能障碍的易感性增加。未来的研究应该调查这些认知差异是否源于APOE4携带者不同的病理级联反应。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7292/11703168/c641690c6edd/nihpp-2024.12.23.630203v1-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7292/11703168/80c745f71cc3/nihpp-2024.12.23.630203v1-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7292/11703168/bed33f926def/nihpp-2024.12.23.630203v1-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7292/11703168/c641690c6edd/nihpp-2024.12.23.630203v1-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7292/11703168/80c745f71cc3/nihpp-2024.12.23.630203v1-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7292/11703168/bed33f926def/nihpp-2024.12.23.630203v1-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7292/11703168/c641690c6edd/nihpp-2024.12.23.630203v1-f0003.jpg

相似文献

1
APOE4 Increases Susceptibility to Amyloid, Accelerating Episodic Memory Decline.APOE4增加对淀粉样蛋白的易感性,加速情景记忆衰退。
bioRxiv. 2024 Dec 24:2024.12.23.630203. doi: 10.1101/2024.12.23.630203.
2
In Thai Nationals, the ApoE4 Allele Affects Multiple Domains of Neuropsychological, Biobehavioral, and Social Functioning Thereby Contributing to Alzheimer's Disorder, while the ApoE3 Allele Protects Against Neuropsychiatric Symptoms and Psychosocial Deficits.在泰国人群中,载脂蛋白 E4 等位基因影响神经心理学、生物行为和社会功能的多个领域,从而导致阿尔茨海默病,而载脂蛋白 E3 等位基因则可预防神经精神症状和社会心理缺陷。
Mol Neurobiol. 2018 Aug;55(8):6449-6462. doi: 10.1007/s12035-017-0848-0. Epub 2018 Jan 6.
3
Precuneus Activity during Retrieval Is Positively Associated with Amyloid Burden in Cognitively Normal Older 4 Carriers.在认知正常的老年4号基因携带者中,检索过程中的楔前叶活动与淀粉样蛋白负荷呈正相关。
J Neurosci. 2025 Feb 5;45(6):e1408242024. doi: 10.1523/JNEUROSCI.1408-24.2024.
4
Differential effects of aging, Alzheimer's pathology, and APOE4 on longitudinal functional connectivity and episodic memory in older adults.衰老、阿尔茨海默病病理学及APOE4对老年人纵向功能连接和情景记忆的不同影响。
Alzheimers Res Ther. 2025 Apr 25;17(1):91. doi: 10.1186/s13195-025-01742-6.
5
Interaction effects of subjective memory impairment and ApoE4 genotype on episodic memory and hippocampal volume.主观记忆障碍和 ApoE4 基因型对情景记忆和海马体积的交互作用。
Psychol Med. 2011 Sep;41(9):1997-2006. doi: 10.1017/S0033291711000067. Epub 2011 Feb 2.
6
ApoE4 and Connectivity-Mediated Spreading of Tau Pathology at Lower Amyloid Levels.载脂蛋白 E4 与 Tau 病理连接性传播在较低淀粉样蛋白水平。
JAMA Neurol. 2023 Dec 1;80(12):1295-1306. doi: 10.1001/jamaneurol.2023.4038.
7
Neuroimaging biomarkers for Alzheimer's disease in asymptomatic APOE4 carriers.无症状 APOE4 携带者的阿尔茨海默病神经影像学生物标志物。
Rev Neurol (Paris). 2013 Oct;169(10):729-36. doi: 10.1016/j.neurol.2013.07.025. Epub 2013 Sep 6.
8
Effects of apolipoprotein E4 genotype on cerebro-cerebellar connectivity, brain atrophy, and cognition in patients with Alzheimer's disease.载脂蛋白 E4 基因型对阿尔茨海默病患者的脑-小脑连接、脑萎缩和认知的影响。
J Neurol Sci. 2022 Nov 15;442:120435. doi: 10.1016/j.jns.2022.120435. Epub 2022 Sep 23.
9
Don't forget about tau: the effects of ApoE4 genotype on Alzheimer's disease cerebrospinal fluid biomarkers in subjects with mild cognitive impairment-data from the Dementia Competence Network.不要忽视 tau:载脂蛋白 E4 基因型对轻度认知障碍患者阿尔茨海默病脑脊液生物标志物的影响——来自痴呆能力网络的数据。
J Neural Transm (Vienna). 2022 Jun;129(5-6):477-486. doi: 10.1007/s00702-022-02461-0. Epub 2022 Jan 21.
10
Association of β-Amyloid and Apolipoprotein E ε4 With Memory Decline in Preclinical Alzheimer Disease.β-淀粉样蛋白和载脂蛋白 E ε4 与临床前阿尔茨海默病的记忆衰退的关联。
JAMA Neurol. 2018 Apr 1;75(4):488-494. doi: 10.1001/jamaneurol.2017.4325.

本文引用的文献

1
Cerebral hyperactivation across the Alzheimer's disease pathological cascade.阿尔茨海默病病理级联反应中的大脑过度激活。
Brain Commun. 2024 Oct 25;6(6):fcae376. doi: 10.1093/braincomms/fcae376. eCollection 2024.
2
Cognitive modeling of the Mnemonic Similarity Task as a digital biomarker for Alzheimer's disease.作为阿尔茨海默病的数字生物标志物,对记忆相似性任务的认知建模。
Alzheimers Dement. 2024 Oct;20(10):6935-6947. doi: 10.1002/alz.14163. Epub 2024 Sep 6.
3
Digital cognitive assessments as low-burden markers for predicting future cognitive decline and tau accumulation across the Alzheimer's spectrum.
数字认知评估作为预测阿尔茨海默病谱系中未来认知能力下降和 tau 积累的低负担标志物。
Alzheimers Dement. 2024 Oct;20(10):6881-6895. doi: 10.1002/alz.14154. Epub 2024 Sep 6.
4
Revised criteria for diagnosis and staging of Alzheimer's disease: Alzheimer's Association Workgroup.修订的阿尔茨海默病诊断和分期标准:阿尔茨海默病协会工作组。
Alzheimers Dement. 2024 Aug;20(8):5143-5169. doi: 10.1002/alz.13859. Epub 2024 Jun 27.
5
Remote and unsupervised digital memory assessments can reliably detect cognitive impairment in Alzheimer's disease.远程和无人监督的数字记忆评估可以可靠地检测阿尔茨海默病患者的认知障碍。
Alzheimers Dement. 2024 Jul;20(7):4775-4791. doi: 10.1002/alz.13919. Epub 2024 Jun 12.
6
APOE4 homozygozity represents a distinct genetic form of Alzheimer's disease.载脂蛋白 E4 纯合子代表一种独特的阿尔茨海默病遗传形式。
Nat Med. 2024 May;30(5):1284-1291. doi: 10.1038/s41591-024-02931-w. Epub 2024 May 6.
7
Characterizing brain tau and cognitive decline along the amyloid timeline in Alzheimer's disease.描述阿尔茨海默病中淀粉样蛋白时间线上的脑 tau 与认知衰退。
Brain. 2024 Jun 3;147(6):2144-2157. doi: 10.1093/brain/awae116.
8
Timing of Biomarker Changes in Sporadic Alzheimer's Disease in Estimated Years from Symptom Onset.散发性阿尔茨海默病从症状出现到估计年份的生物标志物变化时间。
Ann Neurol. 2024 May;95(5):951-965. doi: 10.1002/ana.26891. Epub 2024 Feb 24.
9
Biomarker Changes during 20 Years Preceding Alzheimer's Disease.阿尔茨海默病发病前 20 年的生物标志物变化。
N Engl J Med. 2024 Feb 22;390(8):712-722. doi: 10.1056/NEJMoa2310168.
10
The HOPE4MCI study: A randomized double-blind assessment of AGB101 for the treatment of MCI due to AD.HOPE4MCI研究:AGB101治疗阿尔茨海默病所致轻度认知障碍的随机双盲评估。
Alzheimers Dement (N Y). 2024 Jan 24;10(1):e12446. doi: 10.1002/trc2.12446. eCollection 2024 Jan-Mar.